Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Albumin, Quantity: 40 g/L
CSL Behring Australia Pty Ltd
Albumin
Injection, solution
Excipient Ingredients: octanoate; sodium; chloride
Intravenous
50 mL
(S1) This Schedule is intentionally blank
1. Management of hypovolaemia/shock - Albumex 4 may be used to help to maintain plasma volume. Note that other fluids may be needed in the course of treatment. 2. Cardiopulmonary bypass - Albumex 4 may be used for priming the pump for cardiopulmonary bypass surgery. It may also be used in the management of hypovolaemia following cardiopulmonary bypass surgery. 3. Plasma exchange - Albumex 4 may be used in plasma exchange.
Visual Identification: A clear, pale yellow-green solution; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
1995-12-18